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SUMMARY
Objective/Aim: The aim of this study is to describe the
distribution of the platelet blood group A antigenicity in
Euro-Brazilians (EUBs) and Afro-Brazilians (AFBs).
Background: A small but signiﬁcant proportion of indi-
viduals express high levels of A or B antigen on their
platelets corresponding to the erythrocyte ABO group.
The mechanism of increased antigen expression has not
been elucidated.
Material/Methods: A cohort of 241 blood group A
donors was analysed by ﬂow cytometry. Although mean
ﬂuorescence intensity (MFI) is a typical continuous vari-
able, platelets were screened and divided into two cate-
gories: low expressers (LEs) and high expressers (HEs).
A three-generation family was investigated looking for
an inheritance mechanism.
Results: The prevalence of the HE platelet pheno-
type among group A1 donors was 2%. The mean of
MFI on platelets of A1 subgroup of EUBs differs from
that of AFBs (P = 0·0115), whereas the frequency of
the HE phenotype was similar between them (P =
0·5251). A signiﬁcant difference was found between
sexes (P = 0·0039). Whereas the serum glycosyltrans-
ferase from HE family members converted signiﬁcantly
more H antigen on group O erythrocytes into A anti-
gens compared with that in LE serum, their ABO, FUT1
and FUT2 genes were consensus. The theoretically
favourable, transcriptionally four-repeat ABO enhancer
was not observed.
Conclusion: The occurrence of HE in several mem-
bers suggests familial aggregation. Indeed, in repeated
measures, stability of the MFI values is suggesting an
inherited condition. Factors outside the ABO locus might
be responsible for the HE phenotype. Whether the real
mechanism of inheritance is either of a polygenic or of
a discrete Mendelian nature remains to be elucidated.
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Human platelets express alloantigens that are platelet
speciﬁc (e.g. Human Platelet Antigens (HPA)) and others
that are shared with other blood cells and tissues
(e.g. ABH, P, Le, I and Human Leucocyte Antigens
(HLA) class I determinants) (Kunicki & George, 1989).
Although it has been known for decades that human
platelets express A and B antigens corresponding to
the ABO blood group of the individual’s erythrocytes,
many blood banks worldwide transfuse platelets without
regarding donor–recipient ABO compatibility. Although
this practice might relieve inventory pressures, several
reports have described platelet refractoriness mediated
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by anti-A and anti-B antibodies (Skogen et al., 1988;
Ogasawara et al., 1993; Curtis et al., 2000).
In Japan, approximately 7% of the population ex-
presses signiﬁcantly elevated levels of either A or B
antigen on the platelet surface (Ogasawara et al., 1993).
It has been suggested that the expression of ABH
antigens on platelets is genetically determined and that
individuals can be classiﬁed as either low expressers
(LEs) or high expressers (HEs) depending on the amount
of A or B antigen detectable on their platelets. Curtis
et al. (2000) showed that platelet A antigen levels in
7% of Caucasian blood group A1 donors were higher
than in the general population mean + 2SD using ﬂow
cytometry. The corresponding percentage for B antigen
in B donors was 4%. Furthermore, these investigators
proposed that HE individuals could be divided into two
categories of HEs of group A or B antigen, based on
the ﬂow cytometrically generated histogram pattern. The
amount of these antigens on the platelets in the HE type
I (HE-I) group overlapped with the mean of that in the
general population but was, on average, higher. In the
HE type II (HE-II) group, there was a clear separation
between the amount of platelet A (or B) antigen on these
donors’ platelets and the mean of the general population
as shown by the histogram.
A recent study indicated that individuals with the A2
red blood cell (RBC) phenotype may lack A antigen
as well as its precursor substance H antigen on their
platelets (Cooling et al., 2005), although this ﬁnding has
been questioned by others (Curtis & Aster, 2006). We
have evaluated the amount of A antigen on the platelet
surface of 241 Brazilian blood group A1,A 2 and Aint
donors. This is the largest cohort of A donors studied
so far and also the ﬁrst report about ethnic groups. We
also present a study on a group A1 HE Afro-Brazilian
(AFB) family with a complete analysis of the underlying
ABO gene sequence including its 5  enhancer region,
suggested by some investigators (Gershan et al., 2006)
to play a role in ABO transcriptional platelet regulation.
The FUT1 and FUT2 genes, which are involved in
synthesising the ABO precursor substance (H antigen)
on RBCs and in secretions, respectively, have also been
investigated. The occurrence of HE phenotype in several
members suggests familial aggregation of the character.
The potential mechanism of inheritance of the platelet
HE phenotype is also discussed.
MATERIALS AND METHODS
Specimens
On giving blood, 241 Brazilian group A blood donors
agreed to participate in the study. The study was
approved by the Ethical Scientiﬁc Committee (Comitˆ e
de ´ Etica em Pesquisa, registration number: 001/003,
Hospital Universit´ ario Clementino Fraga Filho/
Faculdade de Medicina, Universidade Federal do Rio
de Janeiro, Brazil), and all subjects received oral and
written information concerning the study and gave their
informed consent. The ethnicity of the donors, either
Euro-Brazilian (EUB) or AFB, was assigned at the time
of blood donation, as previously reported (Palatnik et al.,
2002). Furthermore, a possible bone marrow donor, who
had shown the highest level of platelet A antigen, and his
13 living relatives were also analysed. Informed consent
was obtained from each individual or from the parents
on behalf of their children. All of the family members
were AFBs born in Rio de Janeiro, Brazil.
Following Michelson et al. (2000), for platelet studies,
a 4-mL venous blood sample was collected from each
individual into 3·2% sodium citrate-coated polyethylene
terephthalate tubes (Vacuette®, Greiner Bio-One, Amer-
icana, SP, Brazil). Saliva and additional blood samples
(8 mL in ethylenediaminetetraacetic acid and 10 mL in
tubes without additives) from family members and some
blood donors for platelet ABO antigen reproducibil-
ity tests, glycosyltransferase (GTA) assays and genetic
testing were also obtained as described in subsequent
sections.
Erythrocyte phenotyping
The donors’ blood groups were initially determined by
slide test with monoclonal anti-A and anti-B reagents
(DiaMed, Lagoa Santa, MG, Brazil) and repeated using
the microplate system (DiaMed-MP Test®,D i a M e d ,
Cressier sur Morat, Switzerland). To differentiate be-
tween the A subgroups, anti-A1 (Dolichos biﬂorus,
Biotest, Itapecerica da Serra, SP, Brazil, and mouse
hybridoma, Biotest, Dreieich, Germany) and anti-H (our
own crude extracts of Ulex europaeus seeds and a com-
mercial lectin from Biotest, Brazil) testing were carried
out according to the manufacturers’ instructions. The
deﬁnitions of the A subgroups followed published rec-
ommendations (Palatnik, 1984; see also Daniels, 2002).
Platelet preparation
To avoid ex vivo platelet activation, samples were pro-
cessed within 30 min of blood drawing for all assays
(Mody et al., 1999; Michelson, 2006). Each blood sam-
ple was centrifuged at 22
◦C for 5 min at 500 × g
in a Jouan Model BR 4i centrifuge (Societe Jouan,
St Herblain, France). To minimise the formation of
platelet aggregates, one part of the plasma super-
natant (platelet-rich plasma, PRP) was diluted in two
parts of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES)-buffered saline [0·14 M NaCl, 5 mm KCl,
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1m m MgSO4 and 10 mm HEPES (sodium salt), pH 7·4].
Samples were stabilised by ﬁxation in paraformaldehyde
at a ﬁnal concentration of 1% (Metcalfe et al., 1997;
Mody et al., 1999; Michelson et al., 2000; Michelson,
2006).
Quantitative ﬂow cytometric assay
Fixed platelets (50 μL of PRP aliquot, containing
approximately 8 × 107 μL−1 platelets) were incubated
undisturbed for 30 min in the dark at room tem-
perature with saturating dilutions (predetermined by
titrations) of ﬂuorescein isothiocyanate- (FITC)- and
R-phycoerythrin- (R-PE, PE)-labelled monoclonal anti-
bodies. The antibodies used for dual-colour staining
were (i) anti-CD41 (mouse anti-human CD41, platelet
glycoprotein IIb/IIIa R-PE, Dako Cytomation, Glostrup,
Denmark) and anti-A antibody [FITC-conjugated mouse
IgG3κ anti-A monoclonal antibody, clone NaM87-1F6
(Becton-Dickinson Co., BD Pharmingen, San Diego,
CA, USA)] and (ii) anti-CD41 and anti-H lectin (lectin,
FITC labelled, from U. europaeus UEA I, Sigma Chem-
ical Co., St Louis, MO, USA). The quantity of anti-
body used was sufﬁcient to saturate available A antigen
sites: some assays when repeated by incubating the con-
jugate supernatant with a new platelet aliquot yielded
histograms similar to the initial ones.
In order to control the in vitro activation, ﬁxed
platelets were incubated with anti-CD62p (PE-conju-
gated mouse anti-human CD62p monoclonal antibody,
BD Pharmingen). Any possible neutrophil contamination
was discarded by incubation with anti-CD45 (R-PE mon-
oclonal mouse anti-human CD45, leucocyte common
antigen, Dako). To detect nonspeciﬁc antibody bind-
ing, respective isotype controls (negative controls: R-
PE-conjugated IgG1 mouse monoclonal antibody, Dako;
PE-conjugated IgG1 mouse monoclonal antibody, BD
Pharmingen; and FITC-conjugated mouse IgG3κ,B D
Pharmingen) were also used under the same incubation
conditions described earlier.
After staining, platelets were washed (500 × g,
22
◦C, 5 min) twice in 0·1 M phosphate-buffered saline
(PBS), 0·02% NaN3 (w/v), 0·1% bovine serum albu-
min (BSA) (w/v), pH 7·2–7·4, and resuspended in
500 μL of wash solution (Metcalfe et al., 1997; Mody
et al., 1999; Michelson et al., 2000; Michelson, 2006).
Platelet-bound ﬂuorescence and control samples (50 μL
aliquot of ﬁxed platelets from the same individual)
were analysed within 2 h by ﬂow cytometry (FACSCal-
ibur, BD Pharmingen). Forward scatter vs side scat-
ter and forward scatter vs ﬂuorescence gates (FL) of
platelets were set. A total of 30 000 events per sam-
ple were gated and analysed with the computer software
recommended by the manufacturer (CellQuest™ Soft-
ware, BD Pharmingen).
Results were recorded as the mean ﬂuorescence inten-
sity (MFI) of the platelets positive for both CD41 and
either anti-A or anti-H reagents. Maximal platelet acti-
vation was considered in the order of ≤1·5% (CD62p
expression).
One-colour ﬂuorescence ﬂow cytometry was per-
formed on the RBCs of some individuals. One part of
washed RBCs was diluted in two parts of HEPES/BSA-
buffered saline and stabilised by ﬁxation in paraformal-
dehyde at a ﬁnal concentration of 1% (Metcalfe et al.,
1997; Mody et al., 1999; Michelson et al., 2000; Michel-
son, 2006). An aliquot (5 μL) of ﬁxed RBCs was stained
with either anti-A antibody or anti-H lectin. After stain-
ing, RBCs were washed twice and resuspended in wash
solution before ﬂow cytometry analysis. The results were
reported as the MFI in relation to each ﬂuorochrome.
Serum enzyme activity assays
The 3-α-N-acetylgalactosaminyltransferase (blood group
A GTA) activity was measured in three A1 blood group
HE family members following the method of Yabe et al.
(1989), using serum from ﬁve A1 blood group LE indi-
viduals for comparison. In order to assay the GTA
activity, 200 μLo f1 ·6m m UDP-N-acetylgalactosamine
(Sigma), 400 μLo f0 ·1 M cacodylic acid, pH 6·0 (SPI
Supplies, West Chester, PA, USA), containing 0·1M
MnCl2 (Sigma), and 100 μL of 50% suspension of group
O RBCs treated with 0·1% papain solution (Sigma, lot:
127F8075) were added to 1 mL of each serum. The mix-
ture was agitated at 37
◦C for 1 h. After incubation, the
cells were washed three times in a solution of 0·1M
PBS and 0·5% BSA. A fraction of the converted RBCs
was titrated against human anti-A serum. The remainder,
after paraformaldehyde ﬁxation, as described earlier, was
incubated with FITC-anti-A antibody and tested by ﬂow
cytometry.
Saliva secretion assays
Saliva samples from family members collected in sterile
tubes were immediately inactivated by immersion in
boiling water for 15 min. After centrifugation (2400 ×
g, 10 min), quantitative saliva inhibition tests were
performed, as published elsewhere (Mallory, 1993).
Molecular analysis of the ABO and FUT genes
Some members of the AFB family were subjected to
molecular analysis. An initial ABO genotyping screen
was performed using two independent methods: poly-
merase chain reaction-restriction fragment length poly-
morphism (PCR-RFLP) and PCR-allele-speciﬁc primer
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(ASP) (Olsson & Chester, 1995, 1996; Olsson et al.,
1998, 2001). Direct DNA sequencing of exons 1–7,
as previously described (Olsson et al., 2001), was per-
formed in two samples from family members. In addi-
tion, enhancer repeat PCR was used to determine
the allele-dependent number of CCAAT-binding factors
(CBF/NF-Y) motifs found in this minisatellite region
(approximately 4 kbp upstream of the ABO start codon
in exon 1) (Irshaid et al., 1999).
The coding regions of the FUT1 and FUT2 genes
were ampliﬁed as one fragment per locus (1171 and 1188
bp, respectively) using the following primers: FUT1·1F,
ctcagcctcagagcatttgc; FUT1·3R, gctacttcagaaagtctccctg;
FUT2-43F, ccatctcccagctaacgtgtcc; FUT2+43R, gggag-
gcagagaaggagaaaagg (Yip et al., 2002; Storry et al.,
2004). For sequence analysis, the ampliﬁed DNA bands
were eluted from the gel using the QIAquick gel puriﬁ-
cation kit (Qiagen Nordic, Crawley, UK) and sequenced
directly using an ABI 3130 sequencer (Applied Biosys-
tems, Inc., Foster City, CA, USA) and BigDye® reagents
(Applied Biosystems).
Statistical analysis
Log-transformed (natural logarithms, ln) continuous
variables were used, where appropriate. Furthermore,
when necessary, the log values were converted to
MFI values. The ordinates of the graphics express
the expected values for M = e(μ+VAR/2),a n dS E M =
[(
√
(eVAR − 1)(e2μ+VAR)]/
√
(n − 1), which are based on
the ln (μ and VAR) of the original values read by
ﬂow cytometry, where M is the mean MFI value, VAR
is the variance and SEM is the standard error of the
mean. Groups were compared by Kruskal–Wallis and
Mann–Whitney U tests. Association between variables
was assessed by Spearman’s correlation coefﬁcient. Lin-
ear regression analysis was used to assess the strength
and independence of associations between variables.
Categorical variables were compared by χ2 and Fisher’s
exact tests. Normality of the distributions was checked
by Kolmogorov–Smirnov test. Stability of the MFI val-
ues was checked by one-way anova for three correlated
samples. This analysis involves each subject being mea-
sured in each of the k conditions (repeated measures or
within-subjects design). A single normal distribution vs
two normal mixture or three normal mixture distribu-
tions were checked by expectation-maximization (EM)
algorithm and by Akaike’s information criteria (AIC)
(Pawitan, 2001; Burnham & Anderson, 2002). Statistical
analysis was performed using spss (version 10·0 for Win-
dows), Analyse-it for Microsoft Excel (version 2·07)
and VassarStats software. Differences were considered
signiﬁcant with P values <0·05.
RESULTS
The mean and SD of the population of individual values
of MFI were used to deﬁne the two empirical categories
of A antigen expression on platelets among A1 blood
group donors: LE, values lower or equal to the mean +
1·96 SD; HE, values higher than the mean + 1·96 SD.
Samples from 241 blood group A donors (A1 = 183,
Aint = 17 and A2 = 41) and 50 blood group O donors
were obtained. The ln mean + 1·96 SD = 4·82 was used
to classify the A1 phenotypes: LE = 3·86 ± 0·46 and
HE = 5·02 ± 0·17. The prevalence of platelet HE phe-
notype was estimated in 2% of the A1 blood donors.
Ethnic, age and sex distribution
Differences in the amount of A antigen expressed on
platelets of the A1 donors between ethnic and sex sub-
samples of the population were found to be signiﬁcant
(Fig. 1). There was no correlation between MFI and age
for the A1 individuals (P = 0·5947) (data not shown).
Furthermore, the prevalence of HE phenotype distribu-
tion between EUB and AFB among A1 blood donors
was not signiﬁcant (EUB, LE = 141, HE = 2; AFB,
LE = 39, HE = 1; Fisher’s exact test, P = 0·5251).
Histogram patterns and comparison of antigen quantity
on platelets by expression level
A antigen. Most of the LE platelet phenotype of A1 sub-
group (62·2%) showed very low MFI and peak channel
(PC) proﬁles, chieﬂy in the negative region of the distri-
bution, expressing an asymmetric distribution skewed to
the right. However, the platelets (PLTs) of almost 30% of
the donors showed a wide variation of MFI and PC pro-
ﬁles, ranging from low values near the negative region
of the distribution to those lying borderline with the HE
platelet phenotype values, denoting a bimodal histogram
with high density of A antigen sites. The HE phenotype
among A1 donors has shown a distinctive separate and
symmetric distribution with high MFI and PC proﬁles,
expressing a relatively high density of A antigen sites
(Fig. 2a–c).
Most of the platelets of the Aint individuals (n = 11)
have shown proﬁles very similar to those observed
among most of the LE platelet phenotypes of A1 sub-
group. However, there were a few individuals (n =
6) with a slightly higher density of A antigen sites
(Fig. 2e,f). The platelets of group O and subgroup A2
donors could not be distinguished by visual inspection
of the histogram (data not shown).
H antigen. The histogram pattern for all the A variants
were similar to a unimodal distribution, reﬂecting similar
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Fig. 1. Ethnic and sexual differences. (a) Ethnic differences. The amount (MFI) of A antigen on platelets of the A1 subgroup
between EUB (n = 143) and AFB (n = 40) was signiﬁcantly different (Mann–Whitney = 2111·5; Z = 2·53, P = 0·0115). No
signiﬁcant differences were found for the A2 subgroup (EUB, n = 33; AFB, n = 8) (Mann–Whitney = 108·0; Z = 0·79,
P = 0·4296). Aint subgroup was not analysed due to the small sample size (n = 17). (b) Sexual differences. The amount (MFI) of
A antigen expressed on platelets of the A1 subgroup between male (n = 117) and female (n = 66) was signiﬁcant
(Mann–Whitney = 2867·5; Z = 2·89, P = 0·0039). Bars denote ±1S E M .
and very high MFI and PC proﬁles (Fig. 2g–i). Both
patterns (A and H antigens) were reproducible in blood
samples drawn along the time.
Distribution of the A ﬂuorescence intensity on platelets
among subgroups
A1,A 2 and Aint donors differ signiﬁcantly among
themselves (Fig. 3a). Differences between the MFI on
platelets of A1 and A2 (P<0·0001), A1 and Aint
(P = 0·0011), and A2 and Aint (P = 0·0055) donors
were also signiﬁcant. Furthermore, PLTs of A2 donors
differ signiﬁcantly from those of O blood group indi-
viduals (Mann–Whitney A2 vs O 357·0; Z = 5·33, P<
0·0001). The strength of this reactivity on RBC’s control
cells showed the same pattern as on platelets, however,
with higher values (Fig. 3b).
Distribution of the H ﬂuorescence intensity on platelets
among subgroups
Several control tests were performed with RBCs to
verify the standardisation of U. europaeus anti-H lectin.
These studies conﬁrmed the expected results with the
working dilution of the anti-H lectin. The gradient of
the H reactivity of RBCs shows the classical results
expected for U. europaeus lectin (Fig. 3b). However, the
H reactivity of the platelets does not follow a regular
pattern and no signiﬁcant differences were observed
(Fig. 3a).
Distribution of A and H MFI within subgroups
There are two ways to analyse the relationship of A and
H content of platelets, one of them was described above
comparing the respective amount of intensity of ﬂuores-
cence among subgroups (Fig. 3a,b). The other approach
is to examine the correlation and linear regression of
both the parameters. Under this approach, linear regres-
sion for both, EUB and AFB, is shown in Fig. 4.
Variability of MFI individual values
The expresser character may manifest the inherited ten-
dency to remain the same (phenotypic stability) and
the tendency to change in response to current envi-
ronmental conditions. The test for correlated samples
is useful in removing the effects of pre-existing indi-
vidual differences (named SSwg or subjects, extraneous
to the principal question of the test), leaving only the
error (random variability). The variability inside the sam-
ples reﬂects the fact that there is substantial difference
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Fig. 2. Histogram patterns for the blood group A and H antigen expression on platelet membranes. Platelets were dual labelled
with (i) a platelet-speciﬁc monoclonal antibody (PE-CD41) and FITC-labelled anti-human blood group A monoclonal antibody
(a–c, e and f) and (ii) PE-CD41 and FITC anti-H U. europaeus lectin (FITC-UEA I) (g–i). (a and b) The variability patterns of
the LE phenotype and (c) the HE phenotype for the A1 subgroup. (d) IgG3κ isotype control for anti-human blood group A. (e and
f) Sample histograms of platelets of Aint population. The last column (g–i) shows the same platelet samples shown in a–c
exposed to the FITC-UEA I.
among people with respect to the variable ﬂuorescence
intensity. Samples of platelets from 20 individuals of
A1 subgroup were studied at 0, 30 and 45 days. The
results showed that between groups SS = 0·2749, d.f. =
2, MS = 0·1375, F = 2·1756, P = 0·127479, where
SS is the squared sum and MS is the mean square.
The variability within days was great; however, when
the pre-existing individual differences within each day
were removed, the remaining value, the error, which
represents the effect of the random variability, and
the value of F = MSbetween/error = 0·1375/0·0632 =
2·1756 were not signiﬁcant. Days 0, 30 and 45 have
shown a Gaussian distribution of the ln of the MFI
individual values (data not shown). One-way anova
for three correlated samples also showed no signiﬁcant
variation (P = 0·127479). This result indicated that
there was stability of the MFI values, suggesting an
inherited condition.
EM algorithm
The values for the MFI of A antigen on platelets of
each blood group A1 individual were subjected to a
likelihood ratio test using the EM algorithm (Pawitan,
2001). The results of the likelihood ratio χ2 test statistics
when testing a single normal vs a two-component normal
mixture [χ2
d.f.=5−2=3 =− 2(l2 − l1) =− 2(−123·0930 +
122·1244) = 1·9372, P = 0·5 − 0·6] or a three-compo-
nent normal mixture [χ2
d.f.=8−2=6 =− 2(l1 − l3) =− 2
(−123·0930 + 118·6598) = 8·7944; P = 0·1 − 0·2]
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Fig. 3. Blood group A and H expression on platelets and RBCs. (a) On platelet surface. The ﬂuorescence intensity on platelets
differs signiﬁcantly among subgroup A1,A 2 and Aint donors (Kruskal–Wallis = 90·77, d.f. = 2, P<0·0001) when stained with
anti-human blood group A monoclonal antibody (black columns). A decreasing trend of A strength may be observed. The
reactivity of U. europaeus lectin with platelets (grey columns) does not follow a regular pattern and no signiﬁcant differences
were observed when the H content of the A variants was compared with O blood group donors (Kruskal–Wallis = 1·73, d.f. = 3,
P = 0·6299). (b) On RBC surface. The ﬂuorescence intensity on RBCs differs signiﬁcantly among subgroup A1,A 2 and Aint
donors (Kruskal–Wallis = 50·86, d.f. = 2, P = 0·0001) when stained with anti-human blood group A monoclonal antibody (black
columns). A decreasing trend of A strength and an increasing trend of H (U. europaeus) (grey columns) may be observed.
Signiﬁcant differences were observed when the H content of the A variants was compared (Kruskal–Wallis = 44·69, d.f. = 2,
P<0·0001). Bars denote ±1S E M .
were non-signiﬁcant and also when comparing a two-
component normal mixture and a three-component nor-
mal mixture [χ2
d.f.=8−5=3 =− 2(l2 − l3) =− 2
(−122·1244 + 118·6958) = 6·8572, P = 0·05 − 0·1],
the result was non-signiﬁcant. The graphic representa-
tion is shown in Fig. 5. It was estimated that on aver-
age, 98·4% of the ln MFI values, representing the LE
platelet phenotype, were lower than or equal to the
mean + 2SD, which is in agreement with the normal
distribution theory.
Akaike’s information criteria
When comparing a series of models speciﬁed ap r i o r i ,
the one with the lowest AIC is the ‘best’ one for the
data at hand, being a statistical procedure that provides
a measure of the goodness-of-ﬁt of a model to a set of
data (Burnham & Anderson, 2002). AIC =− 2(LL − p),
where LL is the log likelihood at the maximum likeli-
hood ﬁt and p is the number of parameters of the model.
It is noteworthy that the same data set was used for each
model, i.e. the same observations were used for each
analysis. For A1 blood donors, the data for a single nor-
mal [AIC =− 2(−123·0930 − 2) = 250·186] vs a two-
component normal mixture [AIC =− 2(−122·1244 −
5) = 254·2488] and vs a three-component normal mix-
ture [AIC =− 2(−118·6958 − 8) = 253·3916] have also
shown that the ‘best’ model was that of one single
normal distribution (Fig. 5). These results were similar
to those obtained with the generalised likelihood ratio
test.
AFB family results
A family study was performed on three generations of
relatives of the HE group A1 propositus who demon-
strated the largest amount of platelet A antigen. Blood
group A antigen levels on the RBCs of these fam-
ily members were similar to those of ﬁve platelet LE
AFB donors as measured by serological titrations (titre,
P = 0·6623; titration score, P = 0·8182). However, the
serum GTA from the three HE family members tested
(II-3, II-5 and III-1) was capable of converting more H
antigen on group O RBCs into A antigens compared
with the control GTA from A1 LE donors, as mea-
sured by both serological titrations (log10 end-point titre
mean = 1·88 vs 1·69; P = 0·0145) and ﬂow cytometry
(MFI = 33·79 vs 17·93; P = 0·0026) (data not shown).
All HE family members were secretors, based on either
their Lewis phenotypes or their saliva inhibition studies
(Fig. 6a).
The comparison between the A and H antigen content
of the HE individuals from the population sample with
those of the family members has shown that the value of
A MFI of the population sample HE (mean = 152·93)
falls outside the range of the mean of the HE of the
© 2010 The Authors
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Fig. 4. Linear regression of blood group A and H antigen expression on platelets of the A1 subgroup. The amount of A and H
antigens expressed on platelets of the A1 subgroup are positively correlated, i.e. when A antigen increases, H antigen also
increases (P<0·001). Shown on the left is the A1 blood group of the EUB population. Solid linear ﬁt = 2·934 + 0·436x. Shown
on the right is the A1 blood group of the AFB population. Solid linear ﬁt = 2·823 + 0·4596x. Dotted lines represent 95% CI;
dashed lines represent 95% prediction interval. The other subgroups did not show correlation between A and H antigens expressed
on platelets (Aint, P = 0·1407; A2, P = 0·6168).
Fig. 5. Kernel-smoothed curve of A antigen expression on
platelets from A1 blood donors. A single normal model, with
a mean of the 3·88 ± 0·48 (ln), ﬁtted the data better than a
mixture of two or three distributions when submitted to the
likelihood ratio test by EM algorithm.
family components [mean = 336·97, 95% conﬁdence
interval (CI) 204·80–556·70]. This mean is about 6·4
times higher than the mean of the LE phenotype (52·46).
In relation to the H content of the HE expressers, the
HE of the family components shows a lower content
than the population sample: the mean of the H content
of the HE of the family (30·57 ± 5·32) falls outside the
95% CI of the LE fraction of the population (mean =
119·10, 95% CI 109·46–128·44). The expression of
the A and H antigens on both, platelets and RBCs,
obtained with the propositus blood sample, are shown
(Fig. 6b,c).
Genomic DNA was available for analysis from 8
of 14 of the living family members including 4 of 7
of the HE family members (I-1, II-5, III-5 and III-6),
whose genotypes are indicated in Fig. 6a. By PCR-
RFLP and PCR-ASP analyses, all four of these HE
members were heterozygous for an A1 allele with its
single-unit enhancer region [A101, according to the other
terminology used in the Blood Group Antigen Muta-
tion Database (http://www.bioc.aecom.yu.edu/bgmut)].
Direct DNA sequencing of all seven exons and the ﬂank-
ing intronic regions of the ABO gene in two HE family
members revealed a consensus A1B (A101/B101) geno-
type in one member (I-1) and a consensus A1O1 geno-
type in the other (II-5); no unexpected polymorphisms
were detected. In addition, the entire coding region of
both FUT1 and FUT2 were also analysed in these two
members and no unexpected polymorphisms were iden-
tiﬁed (Yazer et al., 2005).
DISCUSSION
In some donors, our studies did not disclose clear-
cut differences between the LE and HE-I phenotypes,
as described by Curtis et al. (2000). The HE-I pheno-
types from the point of view of MFI values and also
from the histogram patterns cannot always be differen-
tiated from the LE phenotype. For these reasons, we
have included both of them as an LE phenotype. On
account of these experimental results, we included in
the LE platelet phenotype a large spectrum of MFI
values.
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(a) (b)
(c)
Fig. 6. Pedigree of the AFB family and A and H blood group antigen expression in the propositus blood sample. (a) Pedigree of
the family. The shaded boxes indicate the HE individuals determined by ﬂow cytometry. The phenotypes are presented in normal
font, whereas genotypes are presented in italics and the arrow indicates the propositus. CBF refers to the upstream enhancer
region of the ABO gene, and the numbers 1 and 4 reﬂect the number of sequences within this region, i.e. 1 + 4 would indicate a
heterozygote for both a single enhancer unit and a four-repeat enhancer region (see text). (b) Platelets of the propositus. Platelets
were dual labelled with (i) a platelet-speciﬁc monoclonal antibody (PE-CD41) and FITC-labelled anti-human blood group A
monoclonal antibody (on the top) and (ii) PE-CD41 and FITC anti-H U. europaeus lectin (FITC-UEA I) (on the bottom).
(c) RBCs of the propositus. RBCs, when exposed to the FITC-UEA I. All HE individuals in this family demonstrated ﬂow
cytometry histograms similar to the A1 HE propositus.
The A reactivity on platelets follows the same gradient
of MFI values as the respective RBC’s control cells,
which was also described by Cooling (2006).
A positive correlation was observed between A1 and
H variables (Fig. 4). Our results are similar to those
reported by Cooling et al. (2005). The extremely low
levels of the H content on platelets of the family HE
members (in relation to the amount observed in the pop-
ulation sample) (Fig. 6b, on the bottom – propositus/
Fig. 2g–i – population sample), together with the almost
virtual absence of H antigen on RBCs (Fig. 6c) and the
higher levels of serum α-GTA, all agree with the HE-
II platelet phenotype described by Curtis et al. (2000,
2008). Findings made in this family have shown that
these platelets carry signiﬁcantly higher levels of A anti-
gen than other A individuals and have indicated that
essentially all H substance, the substrate for synthesis
of A antigen, was converted to A by the higher active
α-GTA.
Furthermore, our results – A2 and Aint platelet donors
have MFI means signiﬁcantly different from those
obtained with platelets from group O individuals – are
at odds with other reports which have indicated that the
amount of A antigen on most platelets from A2 subgroup
was very weak or undetectable (Holgersson et al., 1990;
Ogasawara et al., 1993; Hou et al., 1996; Curtis et al.,
2000; Julmy et al., 2003). An explanation of this differ-
ence is apparently not related to ethnic origins. Further-
more, the A strength on platelets suggests that, at least
in our population, it may not be appropriate to transfuse
platelets from either A2 or Aint blood donors to group O
patients (chieﬂy, if they receive multiple transfusions for
a rather long time), unless these patients have a previ-
ous test showing weak or null anti-A agglutinin titration
scores.
What remains to be elucidated is the mechanism of
inheritance and the factor(s) responsible for produc-
ing the HE platelet phenotype. The occurrence of HE
in several members suggests familial aggregation. Fur-
thermore, in repeated measures, stability of the MFI
values suggesting an inherited condition was observed.
Polygenic inheritance – which cannot be excluded as a
hypothesis – is demonstrated in the transmission pat-
tern of other continuous or quantitative traits, such as
blood pressure (Lander & Schork, 1994). However, the
inheritance of the trait was considered to be transmit-
ted as a dominant Mendelian character related to the
A or B antigen (Ogasawara et al., 1993; Curtis et al.,
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2000). We believe that since the ﬁrst descriptions of the
trait (Ogasawara et al., 1993; Curtis et al., 2000; Cool-
ing et al., 2005), the intensity of ﬂuorescence, a typical
continuous variable, was described as a practical approx-
imation to a discrete form of two or three phenotypes.
The expresser phenotype appears to be cosegregating
with the A1 and B alleles in the families described by
others (Ogasawara et al., 1993; Curtis et al., 2000, 2008)
and in this study. However, this cosegregation does not
necessarily mean that the A1 and B alleles are condi-
tioning the expresser phenotypes. Against the hypothesis
of a trait linked to the ABO locus, there is the apparent
absence of recombinants in the A or B families.
The pattern of inheritance of the HE platelet phe-
notype demonstrated in the family study (Fig. 6a)
suggests autosomal dominant inheritance of the HE
phenotype-producing factor(s). Similar pedigrees in
Japanese donors demonstrating an inheritance pattern
consistent with autosomal dominance have also been
reported (Ogasawara et al., 1993). This proposed mode
of inheritance whereby the HE-producing factors affect
either the GTA or GTB individually explains why, of
the 106 AB Japanese donors studied, none demonstrated
simultaneously high expression of both A and B antigens
on their platelets (Ogasawara et al., 1993), a fact that
argues for an ABO locus-linked inheritance as opposed
to an independent factor able to ‘boost’ the action of any
ABO transferase present.
Furthermore, Cooling et al. (2005) and the present
report found a linear relationship between the amount
of A and H antigens on the platelet surface of group
A1 donors. We hypothesised that a hyperactive 2-α-l-
fucosyltransferase encoded by the FUT1 or FUT2 loci
might be responsible for producing the HE phenotype by
providing larger quantities of H antigen in secretions and
on RBCs, respectively, which could then be converted
into group A antigens. However, complete analysis
of the FUT1 and FUT2 coding regions in two HE
individuals revealed only genes without any unexpected
polymorphisms consistent with normal H synthesis and
thus do not appear to inﬂuence the expresser status. All
the HE members of the family studied were secretors
of A and H substances, thus the passive adsorption of A
antigens onto the platelets (Dunstan et al., 1985; Kunicki
& George, 1989) cannot be deﬁnitively excluded as a
contributing factor of the HE state, but it must be realised
that based on the frequency of secretor status, this could
merely be a coincidence in this family.
The current data set refutes several previously pro-
posed mechanisms of producing the HE phenotype and
points to other theories of its inheritance. There are an
allele-speciﬁc number of minisatellite repeats in the 5 
enhancer region of the ABO allele (Kominato et al.,
1997; Irshaid et al., 1999). Those enhancers featuring
four repeats are associated with higher rates of tran-
scription in luciferase reporter gene experiments (Yu
et al., 2000). With this in mind, we decided to anal-
yse the 5  promoter region in the HE family members
for which DNA was available. In an earlier study, which
was reported only in abstract form, the presence of the
theoretically favourable four-repeat variable number of
tandem repeats (VNTR) enhancer region associated with
an A1 allele was suggested to cause HE phenotype in
two donors (Gershan et al., 2006). To date, this ﬁnd-
ing has not been presented in full or conﬁrmed by other
investigators. Irshaid et al. (1999) screened 234 donors
of different ethnic/geographic origins and found only a
single Jordanian donor who had an A1 allele in cis with
four repeats. Since then, at least twice as many have
been screened and yet no four-repeat enhancers have
been found associated with the A1 allele (M. L. Olsson,
personal communication). This does not appear to paral-
lel the suggested frequency of HE phenotypes (4–7% in
different studies) if the A1 allele with four repeats really
had a role in the molecular basis of HE. It should also
be noted that there are currently no experimental data to
support the notion that enhancer repeats are important for
ABO transcription in haematopoietic tissue. The studies
suggesting that they do in fact play a role in regulating
the rate of transcription (and thereby theoretically, e.g.
the A or B expression on platelets) were performed in
cell lines of gastric cancer origin (Kominato et al., 1997;
Yu et al., 2000).
In this study, the expected single-unit enhancer region
associated with the A1 allele of HE individuals, the
exons 1–7, including splice sites and the putative
proximal promoter region had no unexpected muta-
tions/polymorphisms. On the contrary, a closer analysis
of the current data reveals some interesting phenomena
that might not necessarily be accounted for by a sim-
ple inheritance pattern. In spite of the consensus ABO
gene in the current platelet HE family members (I-1 and
II-5 individuals), the serum GTA from other HE family
members (II-3 and III-1 individuals) synthesised more
A antigens on group O cells compared with the serum
GTA from A1 LE control donors. The higher than nor-
mal GTA activity has also been previously reported in
other platelet HE individuals (Ogasawara et al., 1993;
Curtis et al., 2000), but it is still unclear if this ﬁnd-
ing is due to a higher concentration of serum GTA or
a qualitatively enhanced enzyme at the same concen-
tration as in LE individuals. Yet another possibility to
explain the varying ABO antigen levels on platelets is
megakaryocyte-related interindividual differences.
The cause of the platelet phenotype remains elusive,
although its aetiology probably lies outside the ABO
locus itself. We have presented data that support both a
single and polygenetic explanation for this phenotype;
© 2010 The Authors
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further research is warranted to more fully elucidate
the cause of this fascinating and potentially clinically
relevant phenomenon.
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